about
Levonorgestrel-IUS system and endometrial manipulationTherapeutic options for management of endometrial hyperplasiaPractice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus StatementNew concepts for an old problem: the diagnosis of endometrial hyperplasiaHistopathological, Immunohistochemical and Therapeutical Assessment of Premalignant Endometrial Lesions in a Hospital Based Series of Cases.Emergence, involution, and progression to carcinoma of mutant clones in normal endometrial tissues.Discovery and validation of methylation markers for endometrial cancer.Enhancer of zeste homolog 2 is involved in the proliferation of endometrial carcinoma.An estrogen-induced endometrial hyperplasia mouse model recapitulating human disease progression and genetic aberrations.Project for the National Program of Early Diagnosis of Endometrial Cancer Part I.LNG-IUS treatment of non-atypical endometrial hyperplasia in perimenopausal women: a randomized controlled trialThe clinical consequences of an ageing world and preventive strategiesClinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases.Identification of a gene expression profile associated with the regulation of angiogenesis in endometrial cancer.Association of endometrial hyperplasia and cancer with a history of gestational diabetes.Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancersNew WHO Classification of Endometrial HyperplasiasThe yield of endometrial aspiration in women with various risk factors and bleeding abnormalities.Methylation status of KLF4 and HS3ST2 genes as predictors of endometrial cancer and hyperplastic endometrial lesions
P2860
Q24603448-DE7B1DED-B367-4283-BA16-465C2B5701E2Q26783569-93C6FA81-6AC9-470E-80ED-3C95A8CA085EQ28069514-AA306F90-5351-4CAA-BDF8-32C45A0A43A0Q28071864-8A0F9C3F-97CD-4F54-B58D-8A407FFD4A7DQ33572868-E5E4F4E8-3E7B-4B61-B8CB-BA6BF662DE16Q33760113-C72C9668-A4B9-4EBC-AD1B-2FD5C4AC8BBBQ34020931-286D7FFF-DBEC-4B66-B472-AB63B22456DDQ34293217-41E6D54B-72E8-476C-AC2B-0E27D5490702Q35928907-4B404392-0CDD-4D4E-A710-C89808AB10B3Q36017677-D1D45B4C-927F-4776-B1F1-174F5336005DQ36817480-D84BFB41-3CAA-4B5B-850B-6ED634FB952DQ37179582-9A5EA7D9-F5FD-4FE2-9B7C-195D2C64E9F8Q37199883-1E1E882D-8E41-45D6-BDBE-4714C854542DQ38665853-FBEA940F-CFEC-4296-B127-EC7FAD139C04Q38675379-32B626E2-CD69-4335-B490-4574A4CE7F52Q41878396-87EF2966-87F4-4EF4-A9AE-CEE93A99B43CQ42062896-2062C09C-1288-4872-B74C-ECCF034089E7Q55016279-84C54235-1C11-4F73-A69A-C3EEBF48E7E7Q58744702-2555DFE7-AE71-404D-9928-4615E0B1CD3D
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Management of endometrial precancers.
@en
Management of endometrial precancers.
@nl
type
label
Management of endometrial precancers.
@en
Management of endometrial precancers.
@nl
prefLabel
Management of endometrial precancers.
@en
Management of endometrial precancers.
@nl
P2093
P2860
P1476
Management of endometrial precancers.
@en
P2093
Cornelia L Trimble
George L Mutter
Mario Leitao
Michael Method
Moss Hampton
Olga Ioffe
Richard Zaino
Robert Higgins
Society of Gynecologic Oncology Clinical Practice Committee
P2860
P304
P356
10.1097/AOG.0B013E31826BB121
P407
P577
2012-11-01T00:00:00Z